|  | |  |  | HYDRIDE-L Basic information | 
 | Product Name: | HYDRIDE-L |  | Synonyms: | HYDRIDE-L;(+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one;BP-2  (LT-EDI);BP-2 (LT-EDI)(Bimaprost、Latanprost);(3aR,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one;2H-Cyclopenta[b]furan-2-one,hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-,(3aR,4R,5R,6aS)-;(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-2-one;Lactondiol B |  | CAS: | 41639-74-1 |  | MF: | C18H22O4 |  | MW: | 302.36 |  | EINECS: |  |  | Product Categories: |  |  | Mol File: | 41639-74-1.mol |  |  | 
|  |  | HYDRIDE-L Chemical Properties | 
 | Boiling point | 509.2±50.0 °C(Predicted) |  | density | 1.286±0.06 g/cm3(Predicted) |  | storage temp. | 2-8°C |  | pka | 14.16±0.20(Predicted) | 
|  |  | HYDRIDE-L Usage And Synthesis | 
 | Uses | PGX 9 is a useful intermediate in the chemoenzymatic synthesis of Latanoprost and Bimatoprost, that are prostaglandin analogs widely used for glaucoma treatment. | 
|  |  | HYDRIDE-L Preparation Products And Raw materials | 
 | Raw materials | 2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-, (3aR,4R,5R,6aS)--->[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl] -2-oxo-2H-cyclopenta[b]furan-5-yl ester-->Dimethyl (2-oxo-4-phenylbutyl)phosphonate |  | Preparation Products | Latanoprost Lactone Diol | 
 |